Innoveren Scientific Inc. (IVRN)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Nov 3, 2025
Innoveren Scientific Market Cap
Innoveren Scientific has a market cap or net worth of $8 as of November 6, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
8.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 9, 2019, Innoveren Scientific's market cap has decreased from 8.65M to 8.00, a decrease of -100.00%. That is a compound annual growth rate of -86.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 8.00 | -99.67% |
| Dec 23, 2024 | 2.40K | -97.89% |
| Dec 29, 2023 | 113.99K | -92.96% |
| Dec 29, 2022 | 1.62M | -82.58% |
| Dec 31, 2021 | 9.30M | 348.79% |
| Dec 31, 2020 | 2.07M | -83.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 666.34M |
| Glass House Brands | 577.78M |
| Northwest Biotherapeutics | 390.01M |
| Silence Therapeutics | 312.22M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 305.39M |
| CytoDyn | 297.30M |